ArticlePhysics and imaging in radiation oncology2026
Deep learning and dual-radiomics model incorporating brachytherapy applicator type to predict radiation-induced acute rectal injury in cervical cancer patients.
Article in Physics and imaging in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Radiation-induced acute rectal injury (RARI) is a common early toxicity after radiotherapy for cervical cancer (CC) and remains difficult to predict before treatment, which can adversely affect life quality of patients. We aimed to develop a combined dual-radiomics and deep learning (DL) model to improve the prediction of RARI in CC patients treated with radiotherapy. Materials and methods: This retrospective study included 200 CC patients from one hospital, randomly divided into training (n = 160), internal validation (n = 40) cohorts and external validation (n = 40) from another hospital. Patients were classified as RARI (CTCAE v5.0 grade ≥ 2) or Non-RARI (grade < 2). Radiomic and dosiomic features were extracted from CT images and dose distributions, and DL features were learned using 3D CNNs. The performance of radiomics, dosiomics, DL and hybrid features models for RARI prediction was compared using the receiver operating characteristic (ROC) curve with measurement of the area under the curve (AUC). Results: For radiomics combining dosiomics, XGBoost achieved the best performance with AUCs of 0.786 and 0.755 in internal and external validation cohorts, respectively. For DL, Resnet_with_CBAM achieved the best performance in the input of combining CT and dose distribution with AUCs of 0.786 and 0.773 in internal and external validation cohorts, respectively. Nomogram integrating radiomics, dosiomics, DL features, and clinical factor improved the AUC to 0.810, 0.803 in internal and external validation cohorts, respectively. Conclusion: The nomogram integrating radiomics, dosiomics, DL, and clinical factors can improve the predictive performance for RARI in CC patients followed by radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.